NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis

NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis

Podrobná bibliografie
Hlavní autoři:	Elson, G, Page, T, Buatois, V, Daubeuf, B, Chatel, L, Cons, L, Lippens, C, Salgado-Pires, S, Ferlin, W, Kosco-Vilbois, M, Midwood, K, Shang, L
Médium:	Conference item
Vydáno:	2011

Podobné jednotky

Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
Autor: Cristiano Xavier Lima, a další
Vydáno: (2015-01-01)

CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Autor: Xavier Chauchet, a další
Vydáno: (2022-05-01)

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
Autor: Evgeny Lvovich Nasonov, a další
Vydáno: (2012-06-01)

ESTATES & GAZETTE NO.0101 - 0103 2001

Raised circulating tenascin-C in rheumatoid arthritis.
Autor: Page, T, a další
Vydáno: (2012)

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
Autor: Min-Chan Park, a další
Vydáno: (2019-05-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Autor: Isaacs, J, a další
Vydáno: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
Autor: Kyle, V, a další
Vydáno: (1991)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
Autor: Isaacs, J, a další
Vydáno: (1992)

Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia
Autor: E L Nasonov, a další
Vydáno: (2008-08-01)

Structural Characterization of Act c 10.0101 and Pun g 1.0101—Allergens from the Non-Specific Lipid Transfer Protein Family
Autor: Andrea O’Malley, a další
Vydáno: (2021-01-01)

Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
Autor: Goh, F, a další
Vydáno: (2012)

Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences.
Autor: Sophie Venet, a další
Vydáno: (2012-01-01)

01.01 ARTERIAL STIFFNESS IS INCREASED IN PAEDIATRIC HEART RECIPIENTS
Autor: E. Sharkey, a další
Vydáno: (2007-08-01)

KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer.
Autor: Meenu Jain, a další
Vydáno: (2011-01-01)

TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
Autor: Clanchy, FIL, a další
Vydáno: (2021)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
Autor: Xiao-Kai Chi, a další
Vydáno: (2023-03-01)

POLYMORPHISM OF MICROSATELLITE MARKER S0101 AMONG INDIGENOUS PIG POPULATIONS OF KERALA
Autor: K. Ariprasath, a další
Vydáno: (2007-01-01)

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)
Autor: E. L. Nasonov, a další
Vydáno: (2022-11-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
Autor: Evgeniy L'vovich Nasonov, a další
Vydáno: (2010-05-01)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
Autor: A.O. Lisitsin, a další
Vydáno: (2009-11-01)

EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
Autor: A.O. Lisitsin, a další
Vydáno: (2009-01-01)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Autor: Isaacs, J, a další
Vydáno: (2004)

15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure
Autor: Robert A. Kelly, a další
Vydáno: (2021-03-01)

Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases
Autor: Yann Dean, a další
Vydáno: (2012-11-01)

Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis
Autor: Song, J, a další
Vydáno: (2021)

DAMPENING INFLAMMATION BY MODULATING TLR SIGNALLING
Autor: Midwood, K
Vydáno: (2011)

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
Autor: George D. Kalliolias, a další
Vydáno: (2024-01-01)

IL-29 Enhances LPS/TLR4-Mediated Inflammation in Rheumatoid Arthritis
Autor: Donghua Xu, a další
Vydáno: (2015-08-01)

Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumours
Autor: Magali eRoche, a další
Vydáno: (2015-08-01)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliot, M, a další
Vydáno: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliott, M, a další
Vydáno: (1993)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Autor: Isaacs, J, a další
Vydáno: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
Autor: Isaacs, J, a další
Vydáno: (2005)

Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.
Autor: Monaco, C, a další
Vydáno: (2011)

RANK+TLR2+ myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis
Autor: Weixin Zhang, a další
Vydáno: (2023-05-01)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
Autor: Bicknell, D, a další
Vydáno: (2001)

A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
Autor: Bicknell, D, a další
Vydáno: (2005)

Splenic proteome profiling in response to Marek’s disease virus strain GX0101 infection
Autor: Chuan Wang, a další
Vydáno: (2024-01-01)

JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
Autor: Jihoon Jeong, a další
Vydáno: (2020-01-01)